Hemorrhagic fever viruses.
This article reviews the epidemiology, pathophysiology, and clinical management of patients with suspected or confirmed viral hemorrhagic fever infection. The focus is on clinical management based on case series from naturally occuring outbreaks of viral hemorrhagic fever infection as well as imported cases of viral hemorrhagic fever encountered in industrialized nations. The potential risk of bioterrorism involving these agents is discussed as well as emergency department and critical care management of isolated cases or larger outbreaks. Important aspects of management, including recognition of infected patients, isolation and decontamination procedures, as well as available vaccines and therapies are emphasized.
Pigott
David C
DC
Department of Emergency Medicine, The University of Alabama at Birmingham, 619 South 19th Street, Birmingham, AL 35249-7013, USA. dpigott@uabmc.edu
D001117:Arenaviridae Infections / Q000175:diagnosis; D023482:Bioterrorism; D003666:Decontamination; D019142:Hemorrhagic Fever, Ebola / Q000175:diagnosis / Q000628:therapy; D006482:Hemorrhagic Fevers, Viral / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy / Q000635:transmission; D006801:Humans; D007835:Lassa Fever / Q000175:diagnosis; D016635:Universal Precautions